4//SEC Filing
Zhang Xiaoming 4
Accession 0000899243-22-006632
CIK 0001796129other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:10 PM ET
Size
5.5 KB
Accession
0000899243-22-006632
Insider Transaction Report
Form 4
Zhang Xiaoming
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-14+34,000→ 34,000 totalExercise: $6.26Exp: 2032-02-13→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001878028
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:10 PM ET
- Size
- 5.5 KB